Isodol

Nimesulide, the active ingredient in Isodol, is a non‑steroidal anti‑inflammatory drug presented as an oral tablet for systemic use. It is indicated for the relief of mild to moderate pain, inflammation associated with osteoarthritis, and dysmenorrhea in adult patients.

GNH USA supplies Isodol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution. Clients benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Nimesulide acts by inhibiting cyclo‑oxygenase‑2, reducing prostaglandin‑mediated inflammation and pain.

- Mild to moderate pain: provides analgesic relief in conditions such as headache, dental pain, and musculoskeletal discomfort. - Osteoarthritis: decreases joint inflammation and improves functional mobility in patients with degenerative joint disease. - Dysmenorrhea: alleviates menstrual cramps by reducing uterine prostaglandin production.

Nimesulide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash: mild erythema or itching. - Elevated liver enzymes: transient increase detected in laboratory tests.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury or failure. - Severe allergic reactions: anaphylaxis or Stevens‑Johnson syndrome. - Renal impairment: acute kidney injury or reduced renal function. - Cardiovascular events: increased risk of myocardial infarction or stroke.

When prescribing Isodol, clinicians should consider several safety measures.

- Assess renal and hepatic function: evaluate baseline kidney and liver tests before initiating therapy. - Avoid in patients with known hypersensitivity to nimesulide or other NSAIDs. - Use the lowest effective dose for the shortest duration: limit exposure to reduce risk of adverse effects. - Caution in elderly patients: monitor for gastrointestinal bleeding and renal dysfunction. - Concomitant anticoagulants or antiplatelet agents: increase bleeding risk, require close monitoring. - Store at room temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nimesulide can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Concurrent use with other NSAIDs or COX‑2 inhibitors: additive risk of gastrointestinal bleeding and renal toxicity. - Combination with anticoagulants (e.g., warfarin) or antiplatelet drugs: heightened bleeding tendency. - Co‑administration with hepatotoxic agents (e.g., isoniazid, methotrexate): increased risk of liver injury.

Moderate Interactions (Monitor Closely): - Diuretics or ACE inhibitors: may reduce renal perfusion, monitor kidney function. - Lithium therapy: NSAIDs can increase lithium levels, check serum concentrations. - Corticosteroids: combined use may exacerbate gastrointestinal ulcer risk.